Literature DB >> 31712905

Formulation of Direct Compression Zidovudine Tablets to Correlate the SeDeM Diagram Expert System and the Rotary Press Simulator Styl'ONE Results.

Isaac Nofrerias1, Anna Nardi2, Marc Suñé-Pou2,3, Josep M Suñé-Negre2,4, Encarna García-Montoya2,4, Pilar Pérez-Lozano2,4, Montserrat Miñarro2,4, Bernard Bataille5, Josep R Ticó2,4.   

Abstract

The SeDeM diagram expert system has been applied to study Zidovudine and some excipients. From the obtained diagrams, a pharmaceutical formula has been designed. SeDeM diagram ascertains the critical parameters that are suitable for a direct compression. The formula is compressed using a rotary tablet press simulator which emulates rotary tablet press' compression profiles. From these compressions, we study the formula behavior under different industrial production conditions but saving a huge amount of material. The study is done at different compression forces and compression speeds and taking into account the influence of the pre-compression force. The differences observed between the compression profiles are hereby described. The results indicate that the formulation is able to be compressed adequately with the emulated compression profiles and no differences are observed between the final products. Therefore, we can assure that the SeDeM diagram expert system is accurate and robust. Moreover, its results are comparable with the compression results in a rotary tablet press, which has never been described in the pharmaceutical literature before. From the obtained results, it is possible to select the best rotary press to scale-up this formulation.

Entities:  

Keywords:  SeDeM; direct compression; rotary press simulator; tablet formulation; zidovudine

Year:  2019        PMID: 31712905     DOI: 10.1208/s12249-019-1542-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  1 in total

1.  Scaling Tableting Processes from Compaction Simulator to Rotary Presses-Mind the Sub-Processes.

Authors:  Isabell Wünsch; Irene Friesen; Daniel Puckhaber; Thomas Schlegel; Jan Henrik Finke
Journal:  Pharmaceutics       Date:  2020-03-31       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.